Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN7272,030,96
Msft0,25
Nokia4,6094,70,19
IBM0,03
Mercedes-Benz Group AG52,5652,58-1,37
PFE1,02
17.05.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 16.05.2025
Apyx Medical Rg (NASDAQ Cons)
Závěr k 16.5.2025 Změna (%) Změna (USD) Objem obchodů (ks)
1,43 -3,38 -0,05 63 890
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 17.05.2025
Popis společnosti
Obecné informace
Název společnostiApyx Medical Corp
TickerAPYX
Kmenové akcie:Ordinary Shares
RICAPYX.O
ISIN-
Prioritní akciePreference Shares
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 31.12.2024 220
Akcie v oběhu k 07.05.2025 37 793 886
MěnaUSD
Kontaktní informace
Ulice5115 Ulmerton Rd
MěstoCLEARWATER
PSČ33760-4004
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon17 273 842 323
Fax16314215821

Business Summary: Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Apyx Medical Corp revenues decreased 8% to $9.4M. Net loss decreased 45% to $4.2M. Revenues reflect OEM segment decrease of 45% to $1.5M, International segment decrease of 18% to $2.7M, Domestic segment decrease of 3% to $6.7M. Lower net loss reflects Advance Energy segment income totaling $15K vs. loss of $2.9M, Corporate (other) segment loss decrease of 28% to $3.2M.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICS2007Surgical & Medical Instrument Mfg
NAICS1997Surgical and Medical Instrument Manufacturing
SICSurgical And Medical Instruments
SICSurgical And Medical Instruments



  • Poslední aktualizace: 17.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive Vice President, DirectorCharles Goodwin5804.11.202415.12.2017
Chief Financial Officer, Treasurer, Company SecretaryMatthew Hill5504.12.202304.12.2023
Chief Operating OfficerShawn Roman5306.11.202406.11.2024
Senior Vice PresidentMoshe Citronowicz71